ATK-0104:
556,
582
Wasik, AM; Gandy, MN; McIldowie, M; Holder, MJ; Chamba, A; Challa, A; Lewis, KD; Young, SP; Scheel-Toellner, D; Dyer, MJ; Barnes, NM; Piggott, MJ; Gordon, J. Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death. Invest. New Drugs, 1 Aug 2012, 30 (4), 1471-1483. 575 kB. https://doi.org/10.1007/s10637-011-9730-5 #5
Gandy, MN; Mclldowie, M; Lewis, K; Wasik, AM; Salomonczyk, D; Wagg, K; Millar, ZA; Tindiglia, D; Huot, P; Johnston, T; Thiele, S; Nguyen, B; Barnes, NM; Brotchie, JM; Martin-Iverson, MT. Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt’s lymphoma cytotoxicity. Med. Chem. Commun., 1 Oct 2010, 1 (4), 287–293. 177 kB. https://doi.org/10.1039/c0md00108b #11e
N-Isopropyl-3,4-methylenedioxyamphetamine · N-Isopropyl-MDA · MDIP
N-Propyl-3,4-methylenedioxyamphetamine · N-Propyl-MDA · MDPA · MDPR
N-Methyl-α-propyl-3,4-methylenedioxyphenethylamine · METHYL-K
L · α-Bu-MDPEA · α-Butyl-3,4-methylenedioxyphenethylamine
4-Ethenyl-2,5-dimethoxyamphetamine · DOV · DOVI
2,3-MMBDB · α-Ethyl-N,N-dimethyl-2,3-methylenedioxyphenethylamine
2,3-EBDB · N,α-Diethyl-2,3-methylenedioxyphenethylamine
N-Ethyl-N-methyl-3,4-methylenedioxyamphetamine · MDMEA
DMBDB · MMBDB · α-Ethyl-N,N-dimethyl-3,4-methylenedioxyphenethylamine
4-Allyl-3,5-dimethoxyphenethylamine · DAL
2C-CP · 4-Cyclopropyl-2,5-dimethoxyphenethylamine
2C-AL · 4-Allyl-2,5-dimethoxyphenethylamine
2,5-Dimethoxy-4-(1-methylvinyl)phenethylamine · 2C-1MV
2C-2MVE · trans-2,5-Dimethoxy-4-propenylphenethylamine
2C-2MVZ · cis-2,5-Dimethoxy-4-propenylphenethylamine
4-AlO-3-MA · 4-Allyloxy-3-methoxyamphetamine · ALOMA
4-MeO-NEB · 4′-Methoxy-2-(ethylamino)butanophenone